The numerous different types of nanomaterials and paucity of reliable in vivo information on toxicity has resulted in enduring uncertainties associated with health and safety risks, thereby slowing progress in nanotherapeutic assessment and development. This dissertation explores how the embryonic zebrafish model can be applied to prioritize commonly used nanomaterial...
Previous investigation showed that 20 mg/kg BCNU
caused inhibition of sulfobromophthalein (BSP) excretion
and inhibited bile salt independent bile flow (BSIF) in
rats by 48 h after treatment (Hoyt, 1984).
The present investigation demonstrated that BCNU
inhibited the canalicular step in the excretion of BSP.
This was indicated by the...